Fig. 6From: Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trialsChange of GFR in ACEI/ARB group versus placebo or other active agents groupBack to article page